Posted by: Ethan Smith in: ● July 26, 2011
It’s no secret that Life Sciences is one of the most highly regulated industries with ever-increasing obligations and scrutiny. As these requirements increase it is essential that you are prepared for changes that you can expect will continue to come. Life Sciences companies should build into their operational structure a plan for continuous change and [...]
Posted by: Ethan Smith in: ● January 25, 2011
As 2011 gets into full swing, I can’t help but think about the impending federal regulations forcing pharmaceutical companies to document, track and report payments to physician and physician owned entities, set to begin at the end of the year. In its annual Predicts 2011 series, Gartner recently published a list of predictions for the [...]
Posted by: Ethan Smith in: ● September 8, 2010
Among the litany of headlines recently blasting pharmaceutical, biotech and medical device companies, Allergan – the makers of Botox – has been the latest scapegoat. The past week’s news has been full of stories relating to Allergan’s agreement to settle “off label promotion” charges to the tune of $600M. While the specifics of pleas and [...]
Posted by: Ethan Smith in: ● April 27, 2010
In today’s Life Sciences world everything is becoming increasingly more difficult – all of the “easy” drugs have been discovered, the human genome has been mapped and parts even patented (albeit with much dispute), the blockbuster model has crumbled, cost pressures are intensifying and regulatory scrutiny is at an all time high. The cries for [...]
Posted by: Ethan Smith in: ● January 20, 2010
In lieu of the recent eye-opening study from IDC regarding pharma’s annual revenue leakage, as Metastorm’s Director of Life Sciences Solutions I wish to share the successes of Metastorm’s customers in the life sciences space, to highlight how Metastorm BPM® can (and has) solved this problem, and to improve the financial health of every life [...]
